ASCO: Adding Pembrolizumab to Chemo Improves Survival in Cervical Cancer
Overall and progression-free survival increased for persistent, recurrent, or metastatic cervical cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.